Stamatis Karakonstantis

1.6k total citations · 1 hit paper
48 papers, 1.0k citations indexed

About

Stamatis Karakonstantis is a scholar working on Epidemiology, Molecular Medicine and Pharmacology. According to data from OpenAlex, Stamatis Karakonstantis has authored 48 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Epidemiology, 18 papers in Molecular Medicine and 13 papers in Pharmacology. Recurrent topics in Stamatis Karakonstantis's work include Antibiotic Resistance in Bacteria (18 papers), Antibiotics Pharmacokinetics and Efficacy (13 papers) and Antibiotic Use and Resistance (8 papers). Stamatis Karakonstantis is often cited by papers focused on Antibiotic Resistance in Bacteria (18 papers), Antibiotics Pharmacokinetics and Efficacy (13 papers) and Antibiotic Use and Resistance (8 papers). Stamatis Karakonstantis collaborates with scholars based in Greece, United Kingdom and Belgium. Stamatis Karakonstantis's co-authors include Evangelos I. Kritsotakis, Achilleas Gikas, Πέτρος Ιωάννου, Charalampos Lydakis, George Samonis, Diamantis P. Kofteridis, Loukia Vassilopoulou, Diamantis P. Kofteridis, Maria Basta and George Sourvinos and has published in prestigious journals such as The Journal of Infectious Diseases, Antimicrobial Agents and Chemotherapy and Journal of Affective Disorders.

In The Last Decade

Stamatis Karakonstantis

48 papers receiving 1.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cefiderocol: Systematic Review of Mechanisms of Resistance, Heteroresistance and In Vivo Emergence of Resistance

2022 167 citations Stamatis Karakonstantis, Evangelos I. Kritsotakis et al. profile →

Peers

Countries citing papers authored by Stamatis Karakonstantis

Since Specialization

Citations

This map shows the geographic impact of Stamatis Karakonstantis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stamatis Karakonstantis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stamatis Karakonstantis more than expected).

Fields of papers citing papers by Stamatis Karakonstantis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stamatis Karakonstantis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stamatis Karakonstantis. The network helps show where Stamatis Karakonstantis may publish in the future.

Co-authorship network of co-authors of Stamatis Karakonstantis

This figure shows the co-authorship network connecting the top 25 collaborators of Stamatis Karakonstantis. A scholar is included among the top collaborators of Stamatis Karakonstantis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stamatis Karakonstantis. Stamatis Karakonstantis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Comparative effectiveness of two antimicrobial regimens for the treatment of pan-drug-resistant Acinetobacter baumannii infections: results from the DESPAIR study 2026 ·Antimicrobial Agents and Chemotherapy ·(unknown), (unknown), (unknown), (unknown), (unknown), Aikaterini Gkoufa, (unknown), (unknown), Alexandra Gavala, (unknown), Stamatis Karakonstantis, (unknown), (unknown), (unknown), Athanasios G. Papathanasiou, Maria Pirounaki, (unknown), (unknown), (unknown), George L. Daikos, (unknown)	1
2	The Care Continuum of Patients With Influenza in the Post–COVID-19 Era: A Position Paper 2025 ·The Journal of Infectious Diseases ·Stamatis Karakonstantis, Theodore Lytras, Şiran Keske, Sotirios Tsiodras, Lea Papst, Πέτρος Ιωάννου, (unknown), (unknown), Giulia De Angelis, Virginie Prendki, Cornelia Adlhoch, Pasi Penttinen, Jordi Rello, G. Gavazzi, Surbhi Malhotra‐Kumar, Chrysanthi Skevaki, (unknown), Barbara Rath	1
3	Are cefiderocol or sulbactam/durlobactam better than alternative best available treatment for infection by carbapenem-resistant A. baumannii? A systematic literature review 2025 ·Infection ·Stamatis Karakonstantis, Πέτρος Ιωάννου, Diamantis P. Kofteridis	5
4	Mortality due to carbapenem-resistant Acinetobacter baumannii bacteraemia: a 5-year cohort study in intensive care patients 2025 ·Clinical Microbiology and Infection ·Stamatis Karakonstantis, Evangelos I. Kritsotakis, Nikolaos Tziolos, Loukia Vassilopoulou, (unknown), (unknown), (unknown), (unknown), Sofia Kokkini, Kyriaki Tryfinopoulou, Πέτρος Ιωάννου, Εumorfia Kondili, Diamantis P. Kofteridis	1
5	Disseminated Cryptococcosis With Prostate Involvement in a Patient With T-cell Prolymphocytic Leukemia and Prostate Cancer 2024 ·Cureus ·Anastasios Ioannidis, (unknown), (unknown), (unknown), Stamatis Karakonstantis, (unknown), Ηλίας Δράκος, Charalampos Mamoulakis	1
6	A Retrospective Study of Staphylococcus aureus Bacteremia in a Tertiary Hospital and Factors Associated with Mortality 2023 ·Diagnostics ·Πέτρος Ιωάννου, (unknown), (unknown), (unknown), (unknown), (unknown), Stamatis Karakonstantis, Sofia Maraki, George Samonis, Diamantis P. Kofteridis	4
7	In search for a synergistic combination against pandrug-resistant A. baumannii; methodological considerations 2022 ·Infection ·Stamatis Karakonstantis, Πέτρος Ιωάννου, (unknown)	18
8	Actinotignum schaalii infection – a case series from a tertiary hospital in Greece 2022 ·GERMS ·Πέτρος Ιωάννου, Stamatis Karakonstantis, (unknown), Nikolaos Kontopodis, Sofia Maraki, (unknown), Diamantis P. Kofteridis	1
9	Systematic review and meta-analysis of the proportion and associated mortality of polymicrobial (vs monomicrobial) pulmonary and bloodstream infections by Acinetobacter baumannii complex 2021 ·Infection ·Stamatis Karakonstantis, Evangelos I. Kritsotakis	24
10	Suicidal ideation in adolescents and young adults in Greece: prevalence and association with sociodemographic variables, mental health and substance use 2021 ·European Child & Adolescent Psychiatry ·Maria Basta, Katerina Micheli, Stamatis Karakonstantis, Katerina Koutra, (unknown), (unknown), (unknown), Panagiotis G. Simos, Dimitrios Anagnostopoulos, Alexandros N. Vgontzas, Nikos Papadakis	8
11	A systematic review of implications, mechanisms, and stability of in vivo emergent resistance to colistin and tigecycline in Acinetobacter baumannii 2020 ·Journal of Chemotherapy ·Stamatis Karakonstantis	35
12	A Systematic Review of Implications, Mechanisms, and Stability of In Vivo Emergent Resistance to Colistin and Tigecycline in <em>Acinetobacter baumannii</em> 2020 ·Preprints.org ·Stamatis Karakonstantis	1
13	Excess mortality due to pandrug-resistant Acinetobacter baumannii infections in hospitalized patients 2020 ·Journal of Hospital Infection ·Stamatis Karakonstantis, Achilleas Gikas, (unknown), Evangelos I. Kritsotakis	60
14	Treatment options for K. pneumoniae, P. aeruginosa and A. baumannii co-resistant to carbapenems, aminoglycosides, polymyxins and tigecycline: an approach based on the mechanisms of resistance to carbapenems 2020 ·Infection ·Stamatis Karakonstantis, Evangelos I. Kritsotakis, Achilleas Gikas	119
15	NEET status among young Greeks: Association with mental health and substance use 2019 ·Journal of Affective Disorders ·Maria Basta, Stamatis Karakonstantis, Katerina Koutra, (unknown), (unknown), (unknown), (unknown), Alexandros N. Vgontzas, Panagiotis G. Simos, Nikos Papadakis	23
16	Is coverage of S. aureus necessary in cellulitis/erysipelas? A literature review 2019 ·Infection ·Stamatis Karakonstantis	11
17	False-Positive Blood Cultures in Acute Leukemia: An Underrecognized Finding 2018 ·Case Reports in Medicine ·Stamatis Karakonstantis, (unknown), (unknown), (unknown)	3
18	Eosinophil count (EC) as a diagnostic and prognostic marker for infection in the internal medicine department setting 2018 ·Romanian Journal of Internal Medicine ·Stamatis Karakonstantis, (unknown), (unknown), Charalampos Lydakis	16
19	A significant percentage of patients with transrectal biopsy-related infections have positive blood cultures but negative urine cultures. A literature review and meta-analysis 2018 ·Infectious Diseases ·Stamatis Karakonstantis, (unknown)	3
20	A rare case of acute transverse myelitis associated with Staphylococcus aureus bacteremia and osteomyelitis 2017 ·Spinal Cord Series and Cases ·Stamatis Karakonstantis, (unknown), (unknown), (unknown), (unknown), Charalampos Lydakis	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact